Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice

Cancer Letters

Volumn 112, Issue 2, 1997, Pages 167-175

  Zagon, Ian S ^a   Hytrek, Staci D ^a   Smith, Jill P ^a   McLaughlin, Patricia J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Enkephalin; Neoplasia; Opioid receptor; Pancreatic cancer

Indexed keywords

ENKEPHALIN; GROWTH FACTOR; METENKEPHALIN; OPIATE; OPIATE RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER TRANSPLANTATION; CARCINOGENICITY; CONTROLLED STUDY; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; ISOTOPE LABELING; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; ENKEPHALIN, METHIONINE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; RADIOIMMUNOASSAY; RECEPTORS, OPIOID; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031590965     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04566-1     Document Type: Article

References (28)

1. [1] Alexander, R.W., Upp, J.R., Poston, G.J., Townsend, C.M. and Thompson, J.C. (1988) Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice, Pancreas, 3, 297-302.
2. [2] Barton, C.M., Hall, P.A., Hughes, C.M., Gullick, W.J. and Lemoine, N.R. (1991) Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer, J. Pathol., 163, 111-116.
3. [3] Bleyday, R., Tzanakakis, G.N., Schwalke, M.A., Wanebo, H.J. and Vezeridis, M.P. (1990) Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines, J. Surg. Res., 49, 276-279.
4. [4] Bostwick, D.G., Null, W.E., Holmes, D., Weber, E., Barchas, J.D. and Bensch, K.G. (1987) Expression of opioid peptides in tumors, N. Engl. J. Med., 317, 1439-1443.
5. [5] Feurle, G.E., Helmstaeder, V. and Weber, U. (1982) Met-and leu-enkephalin immuno-and bio-reactivity in human stomach and pancreas, Life Sci., 31, 2961-2969.
6. [6] Gordis, L. and Gold, F.B. Epidemiology and etiology of pancreatic cancer. In: The Exocrine Pancreas: Biology, Pathobiology and Diseases, pp. 621-636. Editors: V.V.L.W. Go, J.D. Gardner, F.P. Brooks, E. Lebenthal, E.P. DiMagno and G.A. Scheele. Raven Press, New York.
7. [7] Hytrek, S.D., McLaughlin, P.J., Lang, C.M. and Zagon, I.S. (1996) Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone, Cancer Lett., 101, 159-164.
8. [8] Hytrek, S.D., Smith, J.P., McGarrity, T.J., McLaughlin, P.J., Lang, C.M. and Zagon, I.S. (1996) Identification and characterization of the ζ opioid receptor in human colon cancer. Am. J. Physiol., in press.
9. [9] Khawaja, X.Z., Green, I.C., Thorpe, J.R. and Titheradge, M.A. (1990) The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat, Biochem. J., 267, 233-240.
10. [10] Komaki, R., Wadler, S., Peters, T., Byhardt, R.W., Order, S., Gallagher, M.J., Iterskovic, A. and Pederson, J. (1992) High-dose irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas: a preliminary report of multi-institutional trial, Cancer, 39, 2807-2812.
11. [11] Korc, M., Chandrasekar, B. and Shah, G.N. (1991) Differential binding and biological activities of epidermal growth factor and transforming growth factor α in a human pancreatic cancer cell line, Cancer Res., 51, 6243-6249.
12. [12] Livingston, E.H., Welton, M.L. and Reber, H.A. (1991) Surgical treatment of pancreatic cancer, The United States experience. Int. J. Pancreatol., 9, 153-157.
13. [13] McLaughlin, P.J. and Zagon, I.S. (1987) Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems, Life Sci., 41, 1465-1472.
14. [14] Murgo, A.J. (1985) Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin, J. Natl. Cancer Inst., 75, 341-344.
15. [15] Polak, J.M., Sullivan, S.N., Bloom, S.R., Facer, P. and Pearse, A.G.E. (1977) Enkephalin-like immunoreactivity in the human gastrointestinal tract, Lancet, 1, 972-974.
16. [16] Poston, G.J., Yao, C.Z., Upp, J.R., Alexander, R.W., Townsend, C.M. and Thompson, J.C. (1988) Vasoactive intestinal peptide inhibits the growth of hamster pancreatic cancer but not human pancreatic cancer in vivo, Pancreas, 3, 439-443.
17. [17] Reubi, J.C., Horisberger, U., Essed, C.E., Jeekel, J., Klijn, J.G.H. and Lamberts, S.W.J. (1988) Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas, Gastroenterology, 95, 760-763.
18. [18] Schmiegel, W., Roeder, C., Schmielau, J., Rodeck, U. and Kalthoff, H. (1993) Tumor necrosis factor α and the epidermal growth factor receptor in human pancreatic cancer cells, Proc. Natl. Acad. Sci. USA, 90, 863-867.
19. [19] Smith, J.P., Fantaskey, A.P., Liu, G. and Zagon, I.S. (1995) Identification of gastrin as a growth peptide in human pancreatic cancer, Am. J. Physiol., 268, R135-R141.
20. [20] Smith, J.P., Shih, A., Wu, Y., McLaughlin, P.J. and Zagon, I.S. (1996) Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion, Am. J. Physiol., 270, R1078-R1084.
21. [21] Tan, M.H., Nowak, N.J., Loor, R., Ochi, H., Sandberg, A.A., Lopez, C., Pickren, J.W., Benjian, R., Douglass, H.O. and Chu, T.M. (1986) Characterization of a new primary human pancreatic tumor, Cancer Invest., 4, 15-23.
22. [22] Upp, J.R., Olson, D., Poston, G.J., Alexander, R.W., Townsend, C.M. and Thompson, J.C. (1988) Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995, Am. J. Surg., 155, 29-34.
23. [23] Warshaw, A.L. and Fernandez-del Castillo, F. (1992) Pancreatic carcinoma. N. Engl. J. Med., 326, 455-465.
24. [24] Wils, J.A. (1991) Chemotherapy in pancreatic cancer: a rational pursuit?, Anti-Cancer Drugs, 2, 3-10.
25. 5]enkephalin) prevents the incidence and retards the growth of human colon cancer, Am. J. Physiol., 271, R780-R786.
26. [26] Zagon, I.S. and P.J. McLaughlin, P.J. (1991) The role of endogenous opioids and opioid receptors in human and animal cancers. In: Stress and Immunity, pp. 343-356. Editors: N.P. Plotnikoff, A.J. Murgo, R.E. Faith and J. Wybran. CRC Press, Caldwell, NJ.
27. [27] Zagon, I.S., McLaughlin, P.J., Goodman, S.R. and Rhodes, R.E. (1987) Opioid receptors and endogenous opioids in diverse human and animal cancers, J. Natl. Cancer Inst., 79, 1059-1065.
28. [28] Zagon, I.S., McLaughlin, P.J. and Smith, J.P. (1994) Opioid growth factor modulation of human pancreatic tumor cells in vitro, Pancreas, 9, 809.